(MENAFN- GlobeNewsWire - Nasdaq) Rising incidence of skin disorders and growing awareness regarding skin care among people around the world are key factors promoting the demand for rosacea treatment.Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global rosacea treatment market size will reach a value of USD 3.16 Billion by 2031 , with a CAGR of 6.5% during the forecast period (2024-2031). High illness prevalence, sophisticated formulations, and proactive government activities are some of the factors driving market expansion. Despite affecting over 400 million individuals globally, rosacea is still not well understood. An estimated 5% of people worldwide are affected by the condition. Fair-skinned people, particularly women, are more likely to have this disorder. Due to a number of similarities in presentation, the condition is frequently misdiagnosed as acne. As a result of numerous patent expirations and off-label medication use, the industry is heavily impacted by generic penetration.
Browse in-depth TOC on the " Rosacea Treatment Market"
Pages – 194
Tables – 94
Figures – 70
To Learn More About This Report, Request a Free Sample Copy -
Rosacea Treatment Market Overview:
| Report Coverage | Details |
| Market Revenue in 2023 | USD 1.79 Billion |
| Estimated Value by 2031 | USD 3.16 Billion |
| Growth Rate | Poised to grow at a CAGR of 6.5% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Drug Class, Mode of Administration and End User |
| Geographies Covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
| Report Highlights | Use of natural ingredients in rosacea treatment products |
| Key Market Opportunities | Growing availability of novel treatment |
| Key Market Drivers | Rising prevalence of rosacea |
Topical Segment to Hold Significant Growth due to its Effectiveness in Targeting Visible Symptoms
The topical segment dominates the global rosacea treatment market due to its effectiveness in targeting visible symptoms like redness and inflammation directly on the skin. An increase in understanding and identifying rosacea, coupled with the inclination towards non-invasive approaches, has contributed to the demand for topical applications. Such admixture tends to be strong within this segment due to better formulation technology, availability, and shaping the global rosacea treatment market outlook positively.
Make an Inquiry to Address your Specific Business Needs :
Antibiotics Segment to Lead Market due to Reduce Inflammation and Control Bacterial Growth
The antibiotics segment leads the global rosacea treatment industry due to their ability to reduce inflammation and control bacterial growth associated with rosacea flare-ups. The emerging tendency towards the prescription of oral as well as topical antibiotics alongside the effectiveness of the above medications in alleviating the symptoms fuels their usage. Moreover, the increasing number of physician prescriptions and the presence of specific antibiotics add to the already existing supremacy of this segment.
North America to Dominate Market due to Strong Healthcare Infrastructure & Strict Regulatory Frameworks
Since the awareness and the early diagnosis and the healthcare facilities are advanced in this region, North America accounts for the largest share of the global rosacea treatment market. In addition, the region is also witnessing increasing prescription medications and topical therapies owing to its emphasis on dermatological treatment. Furthermore, the American society is blessed with the increasing number of cases of rosacea disease and easy availability of dermatologists, which serves to enhance the global rosacea treatment market share.
Rosacea Treatment Market Insight
Drivers:
Growing Awareness and Diagnosis of Rosacea
Innovative Topical Therapies & Oral Antibiotics
Expanding Network of Dermatology Clinics
Restraints:
Side Effects of Rosacea Medications
Rosacea is a Chronic Condition with No Permanent Cure
Treatment Effectiveness can Vary Between Individuals
Take Action Now: Secure Your Rosacea Treatment Industry Today -
Prominent Players in Rosacea Treatment Market
Gary Pharmaceuticals P Limited Hovione Pfizer Inc. PruGen Pharmaceuticals Glenmark Pharmaceuticals Cipla Ltd. VYNE Therapeutics Bayer AG Bausch Health Companies Inc. AbbVie Inc. Eckson Labs Sandoz Spa Galderma Abigail Care Pharmaceutical Aclaris Therapeutics Colorescience, Inc. Croda International Plc Dr. Reddy's Laboratories Ltd Leopharma Lupin
Key Questions Answered in Global Rosacea Treatment Market Report
What is the projected market size and growth rate (CAGR) of the global rosacea treatment industry by 2031? Which segment is expected to dominate the rosacea treatment market? What are some factors driving North America's dominance in the market?
Read Rosacea Treatment Industry Report Today -
This report provides the following insights:
Analysis of key drivers (Availability of effective treatment regimens, income levels rise in emerging markets, growing emphasis on skin health & appearance), restraints (Healthcare plans may not fully cover rosacea treatment, social stigma surrounding skin conditions) opportunities (Rise of telemedicine, non-invasive treatments like laser therapy).
Market Penetration : Comprehensive information on the product portfolios offered by the top players in the rosacea treatment market. Product Development/Innovation : Detailed insights on the upcoming trends, R&D activities, and product launches in the rosacea treatment market. Market Development : Comprehensive information on lucrative emerging regions Market Diversification : Exhaustive information about new products, growing geographies, and recent developments in the market Competitive Assessment : In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Related Reports:
Sacral Nerve Stimulation (SNS) Market is growing at a CAGR of 14.07% in the forecast period (2024-2031)
Microfluidic Devices Market is growing at a CAGR of 17.3% in the forecast period (2024-2031)
Benign Prostatic Hyperplasia Treatment Market is growing at a CAGR of 5.5% in the forecast period (2024-2031)
Long Read Sequencing Market is growing at a CAGR of 30.92% in the forecast period (2024-2031)
Medical Vacuum Systems Market is growing at a CAGR of 6.5% in the forecast period (2024-2031)
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia-Pacific.
Contact Us:
Mr. Jagraj Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email : ...
Visit Our Website :
MENAFN22112024004107003653ID1108913977
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.